Single R-Group Polymorphisms (SRPs) and R-Cliffs: An Intuitive Framework for Analyzing and Visualizing Activity Cliffs in a Single Analog Series

被引:23
作者
Agrafiotis, Dimitris K. [1 ]
Wiener, John J. M. [2 ]
Skalkin, Andrew [1 ]
Kolpak, Jeremy [1 ]
机构
[1] Johnson & Johnson Pharmaceut Res & Dev LLC, Informat, Spring House, PA 19477 USA
[2] Johnson & Johnson Pharmaceut Res & Dev LLC, Med Chem, San Diego, CA 92121 USA
关键词
CATHEPSIN-S; QSAR; SAR; DETERMINANTS; PROTEOLYSIS; INHIBITORS; DISCOVERY; SELECTION; TARGET;
D O I
10.1021/ci200054u
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We introduce Single R-Group Polymorphisms (SRPs, pronounced 'sharps'), an intuitive framework for analyzing substituent effects and activity cliffs in a single congeneric series. A SRP is a pair of compounds that differ only in a single R-group position. Because the same substituent pair may occur in multiple SRPs in the series (i.e., with different combinations of substituents at the other R-group positions), SRP analysis makes it easy to identify systematic substituent effects and activity cliffs at each point of variation SRPs can be visualized as a symmetric heatmap where each cell represents a particular pair of substituents color-coded by the average difference in activity between the compounds that contain that particular SRP. SRP maps offer several advantages over existing techniques for visualizing activity cliffs: 1) the chemical structures of all the substituents are displayed simultaneously on a single map, thus directly engaging the pattern recognition abilities of the medicinal chemist; 2) it is based on R-group decomposition, a natural paradigm for generating and rationalizing SAR; 3) it uses a heatmap representation that makes it easy to identify systematic trends in the data; 4) it generalizes the concept of activity cliffs beyond similarity by allowing the analyst to sort the substituents according to any property of interest or place them manually in any desired order.
引用
收藏
页码:1122 / 1131
页数:10
相关论文
共 51 条
  • [11] Pyrazole-based arylalkyne cathepsin S inhibitors. Part II: Optimization of cellular potency
    Ameriks, Michael K.
    Cai, Hui
    Edwards, James P.
    Gebauer, Damara
    Gleason, Elizabeth
    Gu, Yin
    Karlsson, Lars
    Nguyen, Steven
    Sun, Siquan
    Thurmond, Robin L.
    Zhu, Jian
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (21) : 6135 - 6139
  • [12] Pyrazole-based cathepsin S inhibitors with arylalkynes as P1 binding elements
    Ameriks, Michael K.
    Axe, Frank U.
    Bembenek, Scott D.
    Edwards, James P.
    Gu, Yin
    Karlsson, Lars
    Randal, Mike
    Sun, Siquan
    Thurmond, Robin L.
    Zhu, Jian
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (21) : 6131 - 6134
  • [13] AMERIKS MK, 2009, Patent No. 2009099157
  • [14] Navigating structure-activity landscapes
    Bajorath, Juergen
    Peltason, Lisa
    Wawer, Mathias
    Guha, Rajarshi
    Lajiness, Michael S.
    Van Drie, John H.
    [J]. DRUG DISCOVERY TODAY, 2009, 14 (13-14) : 698 - 705
  • [15] The properties of known drugs .1. Molecular frameworks
    Bemis, GW
    Murcko, MA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (15) : 2887 - 2893
  • [16] BOSTON MA, 2010, ACS NAT M AUG 22 26
  • [17] Using particle swarms for the development of QSAR models based on K-nearest neighbor and kernel regression
    Cedeño, W
    Agrafiotis, DK
    [J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2003, 17 (02) : 255 - 263
  • [18] Broadening access to electronic healthcare databases
    Cepeda, M. Soledad
    Lobanov, Victor S.
    Farnum, Michael
    Weinstein, Rachel
    Gates, Peter
    Agrafiotis, Dimitris K.
    Stang, Paul
    Berlin, Jesse A.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (01) : 84 - 85
  • [19] Endosomal proteolysis and MHC class II function
    Chapman, HA
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (01) : 93 - 102
  • [20] Assessing how well a modeling protocol captures a structure-activity landscape
    Guha, Rajarshi
    Van Drie, John H.
    [J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2008, 48 (08) : 1716 - 1728